EC Paediatrics

Pediatric neurological disorders pose a severe, under-addressed public health crisis in Sub-Saharan Africa. To counter this, the World Medical Aid (WMA) in Bonoua, Ivory Coast, implemented advanced non-pharmacological care.

Their pilot study on children with drug-resistant epilepsy (DRE) successfully utilized Neurofeedback (NF) training, demonstrating a statistically significant and sustained reduction in seizure episodes. This validates NF as a viable, accessible intervention in resource-limited settings.

Sustained funding is crucial for overcoming operational hurdles. Future research will combine NF with multispecies probiotics to modulate the gut-brain axis, creating a holistic treatment strategy to improve neurodevelopmental outcomes and contribute vital data from West Africa.

 Keywords: Drug-Resistant Epilepsy (DRE); Neurofeedback (NF); Pediatric Neurorehabilitation; World Medical Aid (WMA)

1. Senanayake N and Román GC. “Epidemiology of epilepsy in developing countries”. Bulletin of the World Health Organization2 (1993): 247-258.
2. Klein C., et al. “Bridging the neurology healthcare gap in Africa: The imperative of capacity development”. World Neurology1 (2023): 11-13.
3. Olusanya BO., et al. “Cerebral palsy and developmental intellectual disability in children younger than 5 years: Findings from the GBD-WHO Rehabilitation Database 2019”. Frontiers in Public Health 10 (2022): 894546.
4. Wilmshurst JM., et al. “Child Neurology Services in Africa”. Seminars in Pediatric Neurology3 (2011): 173-180.
5. Ogwuche GO., et al. “Neurological diseases at the Pediatric Neurology Clinic in a semi-urban Nigerian tertiary hospital”. Annals of Health Research 2 (2022): 185-194.
6. World Health Organization. “Atlas: Country Resources for Neurological Disorders 2017”. Geneva: WHO Press (2018).
7. Castelletti M., et al. “Treatment of drug-resistant epilepsy with neurofeedback in a pediatric population in ivory coast: a pilot study”. EC Paediatrics9 (2025): 01-08.
8. Cryan JF., et al. “The microbiota-gut-brain axis”. Physiological Reviews4 (2019): 1877-2013.
9. Lin D., et al. “The gut-brain axis in epilepsy: a new target for therapy”. Frontiers in Neurology 14 (2023): 1113054.
10. Sgritta M., et al. “Mechanisms underlying microbial-mediated attenuation of seizures in a mouse model of epilepsy”. Neuron 5 (2019): 981-995.e6.